cardinal health glp-1 receptor agonist weight management diabetes treatments Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic GLP-1 receptor agonists are transforming
Description
Even with insurance, cost-related nonadherence remains prevalent, with patients often skipping doses, delaying fills, or not obtaining needed medications due to cost [133, 134]
Wegovy (Semaglutide) Active ingredient: Semaglutide
The Origin Story: GLP-1 as a Hormone Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by intestinal L-cells in response to food intake
One of these trials also assessed anxiety symptoms and found no effect of liraglutide compared with placebo over 26 weeks in 80 patients with comorbid T2DM and obesity who had previously undergone bariatric surgery 186
The authors emphasised that the findings showed association rather than causation
